Swiss National Bank

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 1582202 ZURICH, V8

Position in FTRE

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,721,034

-$1,366,716 QoQ

Shares Held

182,700

+2.1% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. FTRE ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,600	$332,493,684
2	REGN	Regeneron Pharmaceuticals, Inc.	303,140	$234,218,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	387,720	$128,284,916
4	INSM	INSMED Inc	625,912	$102,349,130
5	RPRX	Royalty Pharma plc	1,191,100	$57,137,067
6	INCY	Incyte Corp	489,774	$46,097,528
7	RVMD	Revolution Medicines, Inc.	425,431	$41,373,164
8	MRNA	Moderna, Inc.	696,100	$35,361,880

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,721,034	182,700	+2.1%	Shares	Sole	2026-05-07
2025-12-31	$3,087,750	179,000	+8.4%	Shares	Sole	2026-02-12
2025-06-30	$815,692	165,120	0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,246,656	165,120	-1.4%	Shares	Sole	2025-05-12
2024-12-31	$3,122,383	167,420	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$3,316,400	165,820	-0.7%	Shares	Sole	2024-11-07
2024-06-30	$3,898,246	167,020	+0.5%	Shares	Sole	2024-08-08
2024-03-31	$6,672,070	166,220	0.0%	Shares	Sole	2024-05-07
2023-12-31	$5,801,078	166,220	-14.7%	Shares	Sole	2024-02-06
2023-09-30	$5,569,903	194,820	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.